EXTRAHEPATIC BILE DUCT ADENOCARCINOMA, BILIARY TYPE

Clinical trials for EXTRAHEPATIC BILE DUCT ADENOCARCINOMA, BILIARY TYPE explained in plain language.

Never miss a new study

Get alerted when new EXTRAHEPATIC BILE DUCT ADENOCARCINOMA, BILIARY TYPE trials appear

Sign up with your email to follow new studies for EXTRAHEPATIC BILE DUCT ADENOCARCINOMA, BILIARY TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo enters early trial for Tough-to-Treat digestive cancers

Disease control Ongoing

This early-stage study is testing a combination of two drugs, guadecitabine and durvalumab, in people with advanced cancers of the liver, pancreas, bile duct, or gallbladder that have spread. The main goals are to find the safest dose and see what side effects occur. Researchers …

Matched conditions: EXTRAHEPATIC BILE DUCT ADENOCARCINOMA, BILIARY TYPE

Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

EXTRAHEPATIC BILE DUCT ADENOCARCINOMA, BILIARY TYPE

Get alerted when new EXTRAHEPATIC BILE DUCT ADENOCARCINOMA, BILIARY TYPE trials appear

New drug duo enters early trial for Tough-to-Treat digestive cancers